Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Bevacizumab Glioblastoma

Olivier Chinot

MD, PhD

🏢Aix-Marseille University and AP-HM🌐France

Professor of Neuro-Oncology

80
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Olivier Chinot led the AVAglio trial investigating bevacizumab with radiotherapy and temozolomide in newly diagnosed glioblastoma, defining the role and limitations of anti-angiogenic therapy in GBM. His work shaped understanding of progression-free survival as an endpoint in GBM trials. He continues to contribute to European neuro-oncology platform trials.

Share:

🧪Research Fields 研究领域

AVAglio bevacizumab GBM
anti-angiogenic therapy glioblastoma
progression-free survival GBM
French neuro-oncology
glioma clinical trial design

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Olivier Chinot 的研究动态

Follow Olivier Chinot's research updates

留下邮箱,当我们发布与 Olivier Chinot(Aix-Marseille University and AP-HM)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment